Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Clinical trial NCT03576014 · UNKNOWN

Trial details

NCT number: NCT03576014
Sponsor: SL VAXiGEN
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cytomegalovirus Infections Preventation of Cytomegalovirus Reactivation BK Virus Infection Preventation of BK Virus Reactivation

Start date: 2018-04-27
Primary completion: 2019-01-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.